Use of isotopically chiral [4′‐13C]famciclovir and 13C NMR to identify the chiral monoacetylated intermediates in the conversion of famciclovir to penciclovir by human intestinal wall extract
- 1 January 1993
- Vol. 5 (8) , 577-582
- https://doi.org/10.1002/chir.530050803
Abstract
Famciclovir is the oral form of the potent antiherpesvirus agent, penciclovir. Hydrolysis of one of the acetyl ester groups of famciclovir creates a chiral centre leading to the possible formation of (R)- and (S)-enantiomers. During its conversion to penciclovir, famciclovir forms two chiral metabolites, namely monoacetyl-6-deoxy-penciclovir and monoacetyl-penciclovir. The absolute configuration and stereospecificity of the monoacetyl metabolites of famciclovir, produced in human intestinal wall extract, were determined using isotopically chiral famciclovir and 13C NMR spectroscopy of the isolated metabolites. 13C NMR showed that the esterase(s), in human intestinal wall extract, hydrolysed the acetyl group preferentially from the pro-(S)-acetoxymethyl group of famciclovir. The specificity of esterase action in forming monoacetyl-6-deoxy-penciclovir and monoacetyl-penciclovir was about 77 and 72%, respectively.Keywords
This publication has 8 references indexed in Scilit:
- Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virusAntimicrobial Agents and Chemotherapy, 1992
- Chemoenzymatic approach to the synthesis of the antiviral agents penciclovir and famciclovir in isotopically chiral [13C] labelled formJournal of the Chemical Society, Perkin Transactions 1, 1992
- Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]Antimicrobial Agents and Chemotherapy, 1989
- Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption propertiesJournal of Medicinal Chemistry, 1989
- Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cellsAntimicrobial Agents and Chemotherapy, 1989
- Some biological properties of BRL 42810, a well absorbed oral prodrug of the antiherpesvirus agent BRL 39123 : M.R. Boyd, R. Boon, S.E. Fowles, K. Pagano, D. Sutton, R.A. Vere Hodge and B.D. Zussman. Beecham Pharmaceuticals, Research Division, Great Burgh, Epsom, Surrey, United KingdomAntiviral Research, 1988
- Synthesis and antiviral activity of 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]purinesJournal of Medicinal Chemistry, 1987
- Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell cultureAntimicrobial Agents and Chemotherapy, 1987